Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9175
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLiu, Kai-Yuan-
dc.contributor.authorChao, Hsiao-Mei-
dc.contributor.authorLu, Yen-Jung-
dc.contributor.authorSu, Ying-Shih-
dc.contributor.authorLee, Wen-Sen-
dc.date.accessioned2024-12-17T04:22:52Z-
dc.date.available2024-12-17T04:22:52Z-
dc.date.issued2022-02-01-
dc.identifier.issn1684-1182-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9175-
dc.description.abstractAbstract Cytomegalovirus (CMV) infection is associated with significant morbidity and mortality in both immunocompetent and immunocompromised patients. CMV is a ubiquitous Herpesviridae virus with a wide spectrum of pathologies in humans. Immunocompetent patients generally develop a benign, self-limited mononucleosis-like syndrome, whereas gastrointestinal tissue-invasive disease is more frequently seen in immunocompromised. The clinical manifestations of CMV colitis or proctitis are demarcated by bloody diarrhea, ulcerations, ulceroinfiltrative changes, and pseudomembranous formation on colonoscopy. Gastrointestinal CMV infections complicated with deep rectal ulcer and fistula formation are rare in patients with systemic lupus erythematosus. Ganciclovir is also the gold standard therapy for CMV colitis or proctitisen_US
dc.language.isoenen_US
dc.publisherElsevier Taiwan LLCen_US
dc.subjectCytomegalovirus;en_US
dc.subjectColitis;en_US
dc.subjectProctitis;en_US
dc.subjectSystemic lupus erythematosus;en_US
dc.subjectGancicloviren_US
dc.titleCytomegalovirus proctitis in non-human immunodeficiency virus infected patients: A case report and literature reviewen_US
dc.typeArticleen_US
Appears in Collections:VOL 55 NO 1 2022

Files in This Item:
File Description SizeFormat 
154-160.pdf1.15 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.